Keyword Analysis & Research: gliptin


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
gliptin1.080.47194797

Keyword Research: People who searched gliptin also searched

Keyword CPC PCC Volume Score
gliptin1.481448111
gliptins list1.960.6714217
gliptin drugs1.710.6201070
gliptin medications0.180.2938483
gliptins diabetes0.410.4717998
gliptiny1.540.8344158
gliptin bnf1.420.4503262
gliptin class1.620.5690812
gliptin moa1.90.4952945
gliptins mechanism of action1.30.3143559
gliptin side effects1.750.168348
gliptine handelsnamen1.330.8469367
gliptine vidal1.810.9953338
gliptine medikamente1.230.6733712

Search Results related to gliptin on Search Engine

  • Dipeptidyl peptidase-4 inhibitor - Wikipedia

    wikipedia.org

    https://en.m.wikipedia.org/wiki/Dipeptidyl_peptidase-4_inhibitor

    WEBInhibitors of dipeptidyl peptidase 4 ( DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2 . The first agent of the class – sitagliptin – was approved by the FDA in 2006. [1]

    DA: 18 PA: 1 MOZ Rank: 66

  • DPP-4 Inhibitors (Gliptins) - Suitability, Benefits & Side Effects

    diabetes.co.uk

    https://www.diabetes.co.uk/diabetes-medication/dpp-4-inhibitors.html

    WEBJan 15, 2019 · Adverse effects of DPP-4 inhibitors include: gastrointestinal problems – including nausea, diarrhoea and stomach pain. flu-like symptoms – headache, runny nose, sore throat. skin reactions – painful skin followed by a red or purple rash. If you have a reaction which causes difficulty breathing or a severe skin reaction, call for medical help.

    DA: 88 PA: 78 MOZ Rank: 65

  • Sitagliptin Uses, Side Effects & Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/mtm/sitagliptin.html

    WEBDec 1, 2023 · Generic name: sitagliptin [ SI-ta-glip-tin ] Brand name: Januvia. Dosage form: oral tablet (100 mg; 25 mg; 50 mg) Drug class: Dipeptidyl peptidase 4 inhibitors. Medically reviewed by Drugs.com on Dec 1, 2023. Written by Cerner Multum. Uses. Side effects. Warnings. Before taking. Dosage. Interactions. FAQ. What is sitagliptin?

    DA: 41 PA: 66 MOZ Rank: 36

  • Gliptins: A New Class of Oral Antidiabetic Agents - PMC

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846464/

    WEBGliptins show significant improvements in glycaemic control and are well tolerated, particularly with regard to weight change and hypoglycemia. Hence, gliptins are considered as useful agents for the treatment of type 2 diabetes mellitus.

    DA: 89 PA: 71 MOZ Rank: 90

  • DPP-4 inhibitors (gliptins) | Diabetes UK

    diabetes.org.uk

    https://www.diabetes.org.uk/guide-to-diabetes/managing-your-diabetes/treating-your-diabetes/tablets-and-medication/dpp-4-inhibitors-gliptins

    WEBDPP-4 inhibitors (gliptins) DPP-4 inhibitors work by blocking the action of DPP-4, an enzyme which destroys the hormone incretin. Incretins help the body produce more insulin only when it is needed and reduce the amount of …

    DA: 91 PA: 36 MOZ Rank: 36


  • Dipeptidyl peptidase 4 inhibitors - Drugs.com

    drugs.com

    https://www.drugs.com/drug-class/dipeptidyl-peptidase-4-inhibitors.html

    WEBDipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and may be used in the treatment of type 2 diabetes. DPP-4 inhibitors slow the inactivation and degradation of GLP-1, a hormone involved in glucose removal from the …

    DA: 14 PA: 94 MOZ Rank: 46

  • Antidiabetic treatment with gliptins: focus on cardiovascular …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587723/

    WEBSep 29, 2015 · Gliptins as a group constitute a widely accepted therapy for the management of T2DM, usually as a second-line medication. Nonetheless, for the time being, a definite relationship between gliptins treatment and improved cardiovascular outcomes remains uncertain and needs yet to be proven.

    DA: 53 PA: 14 MOZ Rank: 59

  • Dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment

    uptodate.com

    https://www.uptodate.com/contents/dipeptidyl-peptidase-4-dpp-4-inhibitors-for-the-treatment-of-type-2-diabetes-mellitus

    WEBApr 27, 2023 · INTRODUCTION. Glucagon-like peptide 1 (GLP-1)-based therapies (eg, dipeptidyl peptidase 4 [DPP-4, DPP4] inhibitors, GLP-1 receptor agonists) affect glycemia through several mechanisms, including enhancement of glucose-dependent insulin secretion, slowed gastric emptying, and reduction of …

    DA: 15 PA: 28 MOZ Rank: 12

  • Dipeptidyl Peptidase IV (DPP IV) Inhibitors - StatPearls - NCBI …

    nih.gov

    https://www.ncbi.nlm.nih.gov/books/NBK542331/

    WEBMay 22, 2023 · Indications. DPP-4 inhibitors, known as gliptins, are a class of oral diabetic medications approved by the Food and Drug Administration (FDA) to treat type 2 diabetes mellitus in adults. DPP-4 inhibitors that have FDA approval include sitagliptin, saxagliptin, linagliptin, and alogliptin.

    DA: 67 PA: 28 MOZ Rank: 19

  • Cardiovascular effects of gliptins | Nature Reviews Cardiology

    nature.com

    https://www.nature.com/articles/nrcardio.2012.183

    WEBJan 8, 2013 · Dipeptidyl peptidase 4 (DPP-4) inhibitors (gliptins) are incretin-based drugs with a role in the management of type 2 diabetes mellitus; they improve glucose control without inducing...

    DA: 51 PA: 50 MOZ Rank: 100